These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4555350)

  • 1. Endocrine factors and risk of venous thrombosis.
    Masi AT
    Milbank Mem Fund Q; 1972 Jan; 50(1):Suppl 2:46-59. PubMed ID: 4555350
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine factors and venous thrombosis.
    Borhani NO
    Milbank Mem Fund Q; 1972 Jan; 50(1):Suppl 2:31-45. PubMed ID: 5030463
    [No Abstract]   [Full Text] [Related]  

  • 3. Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative disease.
    Lang R; Inbal A; Jutrin I; Ravid M
    Isr J Med Sci; 1982 Jun; 18(6):705-7. PubMed ID: 7107208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk associations in the thrombotic disorders.
    Meade TW
    Clin Haematol; 1981 Jun; 10(2):391-405. PubMed ID: 7032782
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic and hematologic factors in venous thrombosis.
    Murphy EA
    Milbank Mem Fund Q; 1972 Jan; 50(1):Suppl 2:71-88. PubMed ID: 4555351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Etiology of deep venous thrombosis observed during thermal cure].
    Ganascia-Goetschel J
    Presse Therm Clim; 1969; 106(4):190-5. PubMed ID: 5408827
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fibrinolytic system in arteriosclerosis.
    O'Brien ET
    J Ir Med Assoc; 1969 Jun; 62(384):203-12. PubMed ID: 4892241
    [No Abstract]   [Full Text] [Related]  

  • 9. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states.
    Feied CF
    Semin Dermatol; 1993 Jun; 12(2):135-49. PubMed ID: 8512794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].
    Drouet L
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1318-26. PubMed ID: 11794976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and patterns of symptomatic thromboembolism in oncohematology.
    Sgarabotto D; Prandoni P; Stefani PM; Scano F; Vianello F; Sartori R; Pietrogrande F; Caenazzo A; Girolami A
    Haematologica; 1998 May; 83(5):442-6. PubMed ID: 9658730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance to activated protein C. A common genetic risk factor in venous thrombosis].
    Berntorp E; Svensson P; Zöller B; Lethagen S; Dahlbäck B
    Lakartidningen; 1995 Sep; 92(39):3587-90. PubMed ID: 7564599
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of hypercoagulability in venous and arterial thrombosis.
    Wessler S
    Cardiovasc Clin; 1971; 3(1):1-16. PubMed ID: 4944368
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Various risk factors in deep venous thrombosis after surgery].
    Wencel D; Chojnacki J
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):849-52. PubMed ID: 6494042
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet coagulant activities and venous thrombosis after hip surgery.
    Walsh PN; Rogers PH; Marder VJ; Gagnatelli G; Escovitz ES; Sherry S
    Trans Assoc Am Physicians; 1974; 87():140-52. PubMed ID: 4617363
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The development of research into the role of the neuro-endocrine system in the pathogenesis of cancer (neuro-endocrine mechanisms of aging and cancer)].
    Dil'man VM
    Vopr Onkol; 1967; 13(10):39-59. PubMed ID: 4877708
    [No Abstract]   [Full Text] [Related]  

  • 20. Defective platelets in essential thrombocythemia.
    Spaet TH; Gaynor E; Goldstein ML
    Arch Intern Med; 1969 Aug; 124(2):135-41. PubMed ID: 5797071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.